v3.26.1
Investment in MiNK Therapeutics, Inc. (Tables)
6 Months Ended
Jun. 30, 2026
Investment Company [Abstract]  
Summarized Balance Sheet Information and Results of Operations The following tables present summarized balance sheet information as of June 30, 2026 and summarized results of operations for the three and six months ended June 30, 2026 (in thousands):

 

 

 

June 30, 2026

 

Current assets

 

$

9,297

 

Non-current assets

 

 

318

 

Current liabilities

 

 

7,569

 

Non-current liabilities

 

 

16,075

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2026

 

Net loss

 

$

(3,128

)

 

$

(5,871

)

Net loss attributable to Agenus

 

 

(1,336

)

 

 

(2,508

)